1From static to dynamic: live observation of the support system after ischemic stroke by two photon-excited fluorescence laser-scanning microscopyXuan Wu，Jia-Rui Li，Yu Fu，Dan-Yang Chen，Hao Nie，Zhou-Ping TangReviews2093-2107
2MicroRNAs in mouse and rat models of experimental epilepsy and potential therapeutic targetsBridget Martinez，Philip V.PeplowReviews2108-2118
3The generation and properties of human cortical organoids as a disease model for malformations of cortical developmentXiu-Ping Zhang，Xi-Yuan Wang，Shu-Na Wang，Chao-Yu MiaoReviews2119-2126
4Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer 's diseaseAziz Unnisa，Nigel H.Greig，Mohammad Amjad KamalReviews2127-2133
5Detection of Alzheimer 's disease onset using MRI and PET neuroimaging: longitudinal data analysis and machine learningIroshan Aberathne，Don Kulasiri，Sandhya SamarasingheReviews2134-2140
6A pancreatic player in dementia: pathological role for islet amyloid polypeptide accumulation in the brainAngelina S.Bortoletto，Ronald J.ParchemReviews2141-2146
7The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrierShuang-Shuang Wei，Le Chen，Feng-Yuan Yang，Si-Qi Wang，Peng WangReviews2147-2155
8Alexander disease: the road aheadMaría A.Pajares，Elena Hernández-Gerez，Milos Pekny，Dolores Pérez-SalaReviews2156-2160
9Mitochondrial dysfunction as a target in spinal cord injury: intimate correlation between pathological processes and therapeutic approachesJulieta Schmidt，Héctor Ramiro QuintáReviews2161-2166
10The role of Rho GTPase family in cochlear hair cells and hearingYu-Bei Dai，Xiang Gao，Dong Liu，Jie GongReviews2167-2172
11Oxidative stress in retinal pigment epithelium degeneration: from pathogenesis to therapeutic targets in dry age-related macular degenerationMeenakshi Maurya，Kiran Bora，Alexandra K.Blomfield，Madeline C.Pavlovich，Shuo Huang，Chi-Hsiu Liu，Jing ChenReviews2173-2181
12Boosting corticospinal system synaptic plasticity to recover motor functionsWeiguo Song，John H.MartinPerspectives2182-2183
13Stable isotope labeling-mass spectrometry as a new approach to determine remyelinationAnddre Osmar Valdivia，Faith Christine Harvey，Sanjoy K.BhattacharyaPerspectives2184-2185
14Regulation of cytohesins by their interactors in the nervous systemYuqi Zhai，King To Leung，Kwok-Fai LauPerspectives2186-2187
15Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discoveryVladimir L.Katanaev，Jana Valnohova，Denis N.Silachev，Yonika A.Larasati，Alexey KovalPerspectives2188-2189
16A perspective on recent findings and future strategies for reactive aldehyde removal in spinal cord injurySeth A.Herr，Anna J.Prall，Riyi ShiPerspectives2190-2191
17Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknownKristen H.Schuster，Hayley S.McLoughlinPerspectives2192-2193
18Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer 's diseaseHyun-ju Lee，Hyang-Sook HoePerspectives2194-2195
19Metabotropic glutamate receptor 1 alpha: a unique receptor variant with variable implications for Alzheimer 's disease pathogenesisJason HY Yeung，Andrea KwakowskyPerspectives2196-2197
20Multi-faceted small molecule for Alzheimer 's diseaseMin Hee Park，Hee Kyung Jin，Jae-sung BaePerspectives2198-2199
